MARC Record from marc_columbia

LEADER: 02170cam a22004578a 4500
001 3917331
005 20221027001308.0
008 850814t19851985maua b 100 0 eng d
010 $a 85004846
020 $a0898387167
035 $a(OCoLC)501400306
035 $a(OCoLC)ocn501400306
035 $a(CStRLIN)NYCM85-B3448
035 $9ADG9682HS
035 $a(NNC)3917331
035 $a3917331
040 $aDNLM/DLC$cDLC$dCStRLIN$dPU-Med$dNNC-M
050 00 $aRC685.A65$bS965 1984
060 0 $aW1 DE997VME$aQV 150 S98972 1984c
082 0 $a616.1/28061$219
111 2 $aSymposium on New Drugs and Devices$n(5th :$d1984 :$cPhiladelphia, Pa.)
245 10 $aCardiac arrhythmias :$bnew therapeutic drugs and devices : proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA, October 4 & 5, 1984 /$cedited by Joel Morganroth, E. Neil Moore.
260 $aBoston :$bM.Nijhoff,$c[1985], ©1985.
300 $axii, 356 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aDevelopments in cardiovascular medicine ;$v47
650 0 $aArrhythmia$xChemotherapy$xEvaluation$vCongresses.
650 0 $aMyocardial depressants$vCongresses.
650 0 $aArrhythmia$xTreatment$xInstruments$vCongresses.
650 0 $aCardiovascular instruments, Implanted$vCongresses.
650 2 $aAnti-Arrhythmia Agents$xstandards.$0https://id.nlm.nih.gov/mesh/D000889Q000592
650 2 $aAnti-Arrhythmia Agents$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D000889Q000627
650 2 $aArrhythmias, Cardiac$xtherapy.$0https://id.nlm.nih.gov/mesh/D001145Q000628
650 2 $aPacemaker, Artificial$xstandards.$0https://id.nlm.nih.gov/mesh/D010138Q000592
650 2 $aPacemaker, Artificial$xtherapeutic use.
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aMorganroth, Joel.$0http://id.loc.gov/authorities/names/n82017045
700 1 $aMoore, E. Neil.$0http://id.loc.gov/authorities/names/n82017044
830 0 $aDevelopments in cardiovascular medicine ;$vv. 47.$0http://id.loc.gov/authorities/names/n42009022
852 00 $boff,hsl$hRC685.A65$iSy63 1984